11:11 AM EDT, 10/24/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.18% to 1,390.31 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and 3D printer company Materialise (MTLS), which surged 20% and 15%, respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and petroleum refiner Equinor ( EQNR ) , which rose 3.4% and 2.8%, respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) , which fell 2.1% and then biopharmaceutical company Grifols ( GRFS ) retreated 1.2%. They were followed by pharmaceutical company Novo Nordisk ( NVO ) and telecommunications company VEON (VEON), which were down 1% and 0.6%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) , which added 19%, and then biopharmaceutical firm Akari Therapeutics ( AKTX ) , which gained 11%. Financial services company Barclays ( JJCTF ) and Lloyds Banking Group ( LYG ) increased 5.5% and 1.4%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Adaptimmune Therapeutics ( ADAP ) , which lost 12% and 1.9%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech firm Autolus Therapeutics ( AUTL ) , which were down 1.7% and 1.3%, respectively.